These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
195 related articles for article (PubMed ID: 24581668)
1. Type 2 diabetes as a redox disease. Watson JD Lancet; 2014 Mar; 383(9919):841-3. PubMed ID: 24581668 [No Abstract] [Full Text] [Related]
2. Hyperinsulinaemia and iron perturbation in patients with type 2 diabetes. Mascitelli L; Pezzetta F; Goldstein MR Int J Clin Pract; 2009 Apr; 63(4):672. PubMed ID: 19335710 [No Abstract] [Full Text] [Related]
3. Metformin Activates AMPK through the Lysosomal Pathway. Zhang CS; Li M; Ma T; Zong Y; Cui J; Feng JW; Wu YQ; Lin SY; Lin SC Cell Metab; 2016 Oct; 24(4):521-522. PubMed ID: 27732831 [No Abstract] [Full Text] [Related]
5. Metformin protects endothelial function in diet-induced obese mice by inhibition of endoplasmic reticulum stress through 5' adenosine monophosphate-activated protein kinase-peroxisome proliferator-activated receptor δ pathway. Cheang WS; Tian XY; Wong WT; Lau CW; Lee SS; Chen ZY; Yao X; Wang N; Huang Y Arterioscler Thromb Vasc Biol; 2014 Apr; 34(4):830-6. PubMed ID: 24482374 [TBL] [Abstract][Full Text] [Related]
6. Cancer research. Cancer prevention with a diabetes pill? Taubes G Science; 2012 Jan; 335(6064):29. PubMed ID: 22223788 [No Abstract] [Full Text] [Related]
7. Altered redox homeostasis in human diabetes saliva. Su H; Velly AM; Salah MH; Benarroch M; Trifiro M; Schipper HM; Gornitsky M J Oral Pathol Med; 2012 Mar; 41(3):235-41. PubMed ID: 22077396 [TBL] [Abstract][Full Text] [Related]
8. Metformin improves cardiac function in rats via activation of AMP-activated protein kinase. Wang XF; Zhang JY; Li L; Zhao XY; Tao HL; Zhang L Clin Exp Pharmacol Physiol; 2011 Feb; 38(2):94-101. PubMed ID: 21143620 [TBL] [Abstract][Full Text] [Related]
10. Differential AMPK phosphorylation by glucagon and metformin regulates insulin signaling in human hepatic cells. Aw DK; Sinha RA; Xie SY; Yen PM Biochem Biophys Res Commun; 2014 May; 447(4):569-73. PubMed ID: 24735537 [TBL] [Abstract][Full Text] [Related]
11. [From cancer to diabetes treatment : the tumor suppressor LKB1 as a new pharmacological target]. Foretz M; Guigas B; Viollet B Med Sci (Paris); 2006 Apr; 22(4):348-50. PubMed ID: 16597397 [No Abstract] [Full Text] [Related]
12. AMPK activation as a strategy for reversing the endothelial lipotoxicity underlying the increased vascular risk associated with insulin resistance syndrome. McCarty MF Med Hypotheses; 2005; 64(6):1211-5. PubMed ID: 15823720 [TBL] [Abstract][Full Text] [Related]
13. Exercise-induced AMPK activity in skeletal muscle: role in glucose uptake and insulin sensitivity. Friedrichsen M; Mortensen B; Pehmøller C; Birk JB; Wojtaszewski JF Mol Cell Endocrinol; 2013 Feb; 366(2):204-14. PubMed ID: 22796442 [TBL] [Abstract][Full Text] [Related]
14. Direct comparison among oral hypoglycemic agents and their association with insulin resistance evaluated by euglycemic hyperinsulinemic clamp: the 60's study. Derosa G; Maffioli P; Salvadeo SA; Ferrari I; Gravina A; Mereu R; Palumbo I; D'Angelo A; Cicero AF Metabolism; 2009 Aug; 58(8):1059-66. PubMed ID: 19394976 [TBL] [Abstract][Full Text] [Related]
15. The combined effect of metformin and L-cysteine on inflammation, oxidative stress and insulin resistance in streptozotocin-induced type 2 diabetes in rats. Salman ZK; Refaat R; Selima E; El Sarha A; Ismail MA Eur J Pharmacol; 2013 Aug; 714(1-3):448-55. PubMed ID: 23845213 [TBL] [Abstract][Full Text] [Related]